Sanofi Ventures backed further by parent group to tune of $625 million

French pharma major Sanofi (Euronext: SAN) has pledged an additional $625 million multi-year capital commitment to its venture capital arm, increasing the fund’s total assets under management to more than $1.4 billion. 

This new commitment to the evergreen venture fund builds on more than a decade of investing in innovative biotech and digital health companies that align with Sanofi’s long-term growth ambitions, the drugmaker says.

'A powerful engine for scientific progress and strategic growth'